National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Location status: Recruiting
Location contact
Jennifer Farren, R.N.
CONTACT
Yogendra Kanthi, M.D.
CONTACT
NCT Number: NCT05403151
Background:
Diseases involving blood, blood vessels, and immune systems are leading causes of death in the United States. Researchers studying these diseases need to compare blood samples from both healthy and sick individuals. Blood samples from healthy people are also used to establish what is normal when developing new tests for diseases and to make sure new testing equipment is working properly.
Objective:
This natural history study will collect blood samples from healthy people. The blood will be used for various kinds of research.
Eligibility:
Healthy adults aged 18 years or older. Pregnant or nursing women will be excluded.
Design:
Participants will have a telehealth visit or telephone call to review their medical history.
They will come to the NIH Clinical Center. They will have a needle inserted into a vein in their arm or hand. About 10 tablespoons of blood will be drawn through the needle.
Researchers may perform a complete blood count, a type of blood test that can help evaluate the participant s overall health. They may do a blood type test.
The blood samples will also be used for genetic studies.
Some blood samples may be stored for use in future research.
Participants may choose to return for repeat visits for up to 10 years. Review of their medical history may also be repeated at later visits. They will receive $50 per blood collection visit.
...
Interested in participating?
Request Info18 year–90 year
All sexes
Observational
Bethesda, Maryland, 20892, United States
Location status: Recruiting
Jennifer Farren, R.N.
CONTACT
Yogendra Kanthi, M.D.
CONTACT
Study Description:
This study will serve to provide tissue samples from individuals with healthy vasculature for mechanistic studies of vascular inflammation and thrombosis.
Objectives:
Primary Objective:
To collect samples from healthy volunteers to:
Endpoints:
This protocol does not have an outcome measure, but rather will be conducted in accordance with Good Clinical Practices for human research solely for the purpose of obtaining blood samples to optimize assays, conduct mechanistic investigations, measure vascular biomarkers, and facilitate the study of vascular and immunologic diseases in patients enrolled in other studies.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Exclusion criteria
An individual who, by self-report, meets the following criteria will be excluded from participation in this study:
-Current pregnancy or lactation
Time frame: Up to 10 Years
This protocol does not have an outcome measure, but will obtain blood samples to optimize assays, conduct mechanistic investigations, measure vascular biomarkers, and facilitate the study of vascular and immunologic diseases in patients enrolled in other studies.
Contact information is provided by the study sponsor or research team.
National Heart, Lung, and Blood Institute (NHLBI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02876601
Bacteremia, Cardiovascular Diseases
Vienna, Austria
View Trial DetailsNCT04790240
Body Temperature Changes, COVID-19
Rockville, Maryland, United States
View Trial DetailsNCT05587036
Fear, Healthy Volunteers
Leuven, Belgium
View Trial DetailsNCT06513611
Acute Coronary Syndrome, Cardiovascular Diseases
Buenos Aires, Argentina
View Trial Details